title: Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts.
abstract: The shear stress resistance of cultured human endothelium was investigated on 6 mm polytetrafluoroethylene vascular grafts. Endothelial cell attachment was promoted by precoating the grafts with fibrin glue, which contained human fibronectin and inhibitors of fibrinolysis (aprotinin and tranexam acid). To evaluate the possible effect of fibrinolysis on cell detachment, seven grafts were lined with adult human saphenous vein endothelial cells (AHSVEC) and 11 with fibrinolytically almost inactive human umbilical vein endothelial cells (HUVEC). Endothelial cell seeding was performed in a microprocessor-controlled rotation device, allowing a low inoculum of 12 X 10(4) endothelial cells/cm2. Grafts were then cultivated for 9 days to enable the maturation of the cytoskeleton, before they were exposed to pulsatile shear stress for 48 hours. A mock circulation simulated the flow patterns and the wall shear forces of the femoral artery. After a 3-hour seeding process, 45% of AHSVEC and 43% of HUVEC were attached to the fibrin matrix, forming a confluent monolayer. After 24 hours of perfusion, a cell loss of 23% in AHSVEC- and of 42% in HUVEC-lined grafts was encountered. In spite of a further cell loss during the following 24 hours of perfusion, the majority of the graft surface was still covered by endothelial cells. Therefore we conclude that fibrin glue is a suitable substrate for the formation of a shear stress-resistant endothelial cell monolayer on polytetrafluoroethylene vascular grafts.
authors: 2nd Department of Surgery, University of Vienna, Austria.
authors: P
authors: P
authors: Zilla
authors: R
authors: R
authors: Fasol
authors: P
authors: P
authors: Preiss
authors: M
authors: M
authors: Kadletz
authors: M
authors: M
authors: Deutsch
authors: H
authors: H
authors: Schima
authors: S
authors: S
authors: Tsangaris
authors: P
authors: P
authors: Groscurth
mesh_terms: D007611:Aprotinin; D001807:Blood Vessel Prosthesis; D002453:Cell Cycle; D004338:Drug Combinations; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D005176:Factor XIII; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen; D006801:Humans; D066298:In Vitro Techniques; D010477:Perfusion; D011138:Polytetrafluoroethylene; D012501:Saphenous Vein / Q000502:physiology; D013314:Stress, Mechanical; D013917:Thrombin; D014014:Tissue Adhesives; D014471:Umbilical Veins / Q000502:physiology
chemical_list: D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives; D005340:Fibrinogen; D011138:Polytetrafluoroethylene; D005176:Factor XIII; D007611:Aprotinin; D013917:Thrombin